Get the Stockscreener App
157.39
2.64%
-4.27
Repligen Corp stock is traded at $157.39, with a volume of 646.68K.
It is down -2.64% in the last 24 hours and down -0.39% over the past month.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
See More
Previous Close:
$161.66
Open:
$161.26
24h Volume:
646.68K
Relative Volume:
0.71
Market Cap:
$8.86B
Revenue:
$633.51M
Net Income/Loss:
$-8.10M
P/E Ratio:
-507.71
EPS:
-0.31
Net Cash Flow:
$131.26M
1W Performance:
-4.60%
1M Performance:
-0.39%
6M Performance:
+19.87%
1Y Performance:
+0.90%
1-Day Range:
$156.31
$162.06
1-Week Range:
$156.31
$165.02
52-Week Range:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Name
Repligen Corp
Sector
Industry
Phone
(781) 449-9560
Address
41 SEYON STREET, WALTHAM, MA
Compare RGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
157.39 | 9.10B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-25 | Initiated | HSBC Securities | Buy |
| Sep-22-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-22-25 | Resumed | Stephens | Overweight |
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-29-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Mar-18-25 | Initiated | Evercore ISI | In-line |
| Feb-10-25 | Initiated | TD Cowen | Buy |
| Dec-17-24 | Initiated | Canaccord Genuity | Hold |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-18-24 | Initiated | Guggenheim | Neutral |
| Dec-04-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Mar-28-23 | Initiated | The Benchmark Company | Buy |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-20-22 | Initiated | UBS | Buy |
| Oct-14-21 | Initiated | Exane BNP Paribas | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| May-07-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-23-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Nov-01-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-15-19 | Initiated | SVB Leerink | Outperform |
| Aug-28-19 | Reiterated | First Analysis Sec | Outperform |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jul-22-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Dec-17-18 | Upgrade | CL King | Neutral → Buy |
| Nov-12-18 | Downgrade | CL King | Buy → Neutral |
| Sep-26-18 | Initiated | H.C. Wainwright | Neutral |
| Dec-08-17 | Initiated | Citigroup | Buy |
| Dec-05-17 | Initiated | JP Morgan | Overweight |
| Nov-13-17 | Initiated | CL King | Buy |
| Oct-02-17 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Jul-21-17 | Initiated | William Blair | Outperform |
| Feb-13-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
View All
Repligen Corp Stock (RGEN) Latest News
Repligen Corporation $RGEN Shares Purchased by First Trust Advisors LP - MarketBeat
What's Driving the Market Sentiment Around Repligen Corp? - Benzinga
The five-year earnings decline is not helping Repligen's (NASDAQ:RGEN share price, as stock falls another 3.3% in past week - Yahoo Finance
London & Capital Asset Management Ltd Lowers Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Norges Bank Buys New Holdings in Repligen Corporation $RGEN - MarketBeat
Nothing is Better Than Repligen Corp (RGEN) stock at the moment - setenews.com
Does Repligen Corporation (RGN) stock trade below intrinsic value2025 Big Picture & Capital Efficiency Focused Ideas - Newser
Brown Capital Management LLC Has $125.04 Million Position in Repligen Corporation $RGEN - MarketBeat
Why Repligen Corporation stock is rated strong buyRecession Risk & Fast Exit/Entry Strategy Plans - Newser
Schroder Investment Management Group Makes New $25.67 Million Investment in Repligen Corporation $RGEN - MarketBeat
Edgestream Partners L.P. Makes New $3.48 Million Investment in Repligen Corporation $RGEN - Defense World
Repligen Corporation (NASDAQ:RGEN) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Repligen Corporation (NASDAQ:RGEN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Loomis Sayles & Co. L P Acquires New Holdings in Repligen Corporation $RGEN - MarketBeat
Is Repligen Corporation stock attractive for hedge fundsPortfolio Value Report & Fast Moving Stock Trade Plans - Newser
Will Repligen Corporation stock outperform Nasdaq indexJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
How Repligen Corporation (RGN) stock reacts to new regulationsJuly 2025 Technicals & Real-Time Volume Triggers - Newser
Advisors Asset Management Inc. Cuts Holdings in Repligen Corporation $RGEN - Defense World
Rhumbline Advisers Lowers Holdings in Repligen Corporation $RGEN - MarketBeat
Coldstream Capital Management Inc. Sells 321 Shares of Repligen Corporation $RGEN - Defense World
American Century Companies Inc. Sells 2,253 Shares of Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Stock Holdings Increased by XTX Topco Ltd - MarketBeat
Aug Chart Watch: Why Repligen Corporation stock is in analyst buy zoneJuly 2025 Opening Moves & Stepwise Trade Signal Guides - moha.gov.vn
AI Stocks: How Repligen Corporation stock reacts to oil prices2025 Geopolitical Influence & Weekly High Return Stock Opportunities - BỘ NỘI VỤ
Insider Sell: Olivier Loeillot Sells 7,041 Shares of Repligen Co - GuruFocus
287,686 Shares in Repligen Corporation $RGEN Bought by Blue Whale Capital LLP - Defense World
Repligen (NASDAQ: RGEN) to Join Evercore Healthcare Conference Webcast Dec. 3 - Stock Titan
Ameritas Investment Partners Inc. Has $2 Million Stake in Repligen Corporation $RGEN - Defense World
Intech Investment Management LLC Buys New Stake in Repligen Corporation $RGEN - MarketBeat
Segall Bryant & Hamill LLC Has $18.48 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Leerink Partnrs Brokers Lift Earnings Estimates for Repligen - Defense World
Why Repligen (RGEN) Stock Is Trading Up Today - Finviz
P/E Ratio Insights for Repligen - Benzinga
Its Stock Has Paid Off Big Time For Repligen Corp - Setenews
Repligen Corporation (RGEN) Stock forecasts - Yahoo Finance UK
RGEN (Repligen) Book Value per Share : $37.01 (As of Sep. 2025) - GuruFocus
Repligen Corporation (RGEN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Repligen Chief Operating Officer Sold $331K In Company Stock - Benzinga
Can Repligen Corporation (RGN) stock sustain margin levelsWeekly Volume Report & Target Return Focused Picks - newser.com
How strong is Repligen Corporation stock balance sheetBear Alert & Risk Managed Investment Strategies - newser.com
Using Python tools to backtest Repligen Corporation strategies2025 Sector Review & Short-Term High Return Strategies - newser.com
Insider Sell: James Bylund Sells Shares of Repligen Corp (RGEN) - GuruFocus
REPLIGEN COO James Bylund Sells 2,191 Shares - TradingView
Real time breakdown of Repligen Corporation stock performanceJuly 2025 Opening Moves & Expert Curated Trade Setups - newser.com
Why Repligen Corporation (RGN) stock is upgraded to buyEarnings Overview Summary & Consistent Return Strategy Ideas - newser.com
Is Repligen Corporation (RGN) stock supported by strong fundamentals2025 Short Interest & Verified Short-Term Trading Plans - newser.com
Repligen at Wolfe Research Healthcare Conference: Strategic Growth Insights - Investing.com
Repligen at Jefferies London: Strategic Growth Amid Headwinds - Investing.com
Insider Selling: Repligen (NASDAQ:RGEN) Director Sells $3,092,200.00 in Stock - Defense World
Smart tools for monitoring Repligen Corporation’s price actionWatch List & Safe Entry Point Identification - newser.com
Custom strategy builders for tracking Repligen CorporationDividend Hike & Free Accurate Trade Setup Notifications - newser.com
Repligen Corp Stock (RGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):